U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Friday.

Shares of Zenas Biopharma Inc (NASDAQ:ZBIO) fell sharply in pre-market trading. Zenas BioPharma announced pricing of concurrent public offerings of 2.50% convertible senior notes due 2032 and common stock with aggregate gross proceeds of $300.0 million.

Zenas Biopharma shares dipped 9.5% to $20.05 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• Daqo New Energy Corp (NYSE:DQ) fell 20% to $17.00 in pre-market trading. Daqo New Energy reported mixed quarterly results on Thursday.
• Armata Pharmaceuticals Inc (NYSE:ARMP) fell 9.1% to $8.50 in pre-market trading. Armata Pharmaceuticals posted a fourth-quarter loss of $3.43 per share after the closing bell on Wednesday.
• Upstream Bio Inc (NASDAQ:UPB) declined 8% to $9.01 in pre-market trading. Upstream Bio on Thursday announced a Phase 3 development strategy for its treatment, verekitug.
• Lithium Argentina AG (NYSE:LAR) fell 6.8% to $6.40 in pre-market trading.
• Enlight Renewable Energy Ltd (NASDAQ:ENLT) declined 6.6% to $67.17 in pre-market trading.
• CVR Partners LP (NYSE:UAN) declined 4.8% to $130.01 in pre-market trading.
• Inventiva ADR (NASDAQ:IVA) fell 4.2% to $5.84 in pre-market trading.
• Nokia Oyj (NYSE:NOK) declined 4.1% to $7.94 in pre-market trading.
• Adient PLC (NYSE:ADNT) fell 4% to $20.50 in pre-market trading.
• Nanobiotix SA – ADR (NASDAQ:NBTX) fell 3.7% to $30.15 in pre-market trading. NANOBIOTIX is scheduled to announce fourth quarter and full year 2025 operational and financial update on March 31.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.